Search research articles
Contact Us
Filters
Showing results (201-210 of 247) with videos related to
Page
of 25
Sort By:
Pediatric Blood & Cancer
|
September 17, 2013
Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program
Hernan Carol, Richard Gorlick, E Anders Kolb, et al.
Frontiers in Cardiovascular Medicine
|
July 1, 2024
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report
Kasey J Leger, Michael J Absalon, Biniyam G Demissei, et al.
Scientific Reports
|
August 27, 2024
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models
Chia-Chin Wu, Licai Huang, Zhongting Zhang, et al.
Cancer
|
November 20, 2023
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia
Jenny Ruiz, Yimei Li, Lusha Cao, et al.
Blood Advances
|
October 20, 2020
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report
Lisa Eidenschink Brodersen, Robert B Gerbing, M Laura Pardo, et al.
Pediatric Blood & Cancer
|
October 1, 2021
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group
Caitlin W Elgarten, Andrew C Wood, Yimei Li, et al.
Blood Advances
|
January 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
Blood
|
July 28, 2021
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial
Johann Hitzler, Todd Alonzo, Robert Gerbing, et al.
Leukemia
|
February 15, 2019
Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
Nicole A McNeer, John Philip, Heather Geiger, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 247) with videos related to
Sort By:
Page
of 25
Pediatric Blood & Cancer
|
September 17, 2013
Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program
Hernan Carol, Richard Gorlick, E Anders Kolb, et al.
Frontiers in Cardiovascular Medicine
|
July 1, 2024
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report
Kasey J Leger, Michael J Absalon, Biniyam G Demissei, et al.
Scientific Reports
|
August 27, 2024
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models
Chia-Chin Wu, Licai Huang, Zhongting Zhang, et al.
Cancer
|
November 20, 2023
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia
Jenny Ruiz, Yimei Li, Lusha Cao, et al.
Blood Advances
|
October 20, 2020
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report
Lisa Eidenschink Brodersen, Robert B Gerbing, M Laura Pardo, et al.
Pediatric Blood & Cancer
|
October 1, 2021
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group
Caitlin W Elgarten, Andrew C Wood, Yimei Li, et al.
Blood Advances
|
January 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
Blood
|
July 28, 2021
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial
Johann Hitzler, Todd Alonzo, Robert Gerbing, et al.
Leukemia
|
February 15, 2019
Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
Nicole A McNeer, John Philip, Heather Geiger, et al.
Page
of 25